Public Views on Prescription Drug Costs: Regulation, Affordability and TrumpRx
Amid the Trump administration’s focus on lowering prescription drug costs, including its new TrumpRx website, KFF’s Health Tracking Poll finds that most Americans (59%) are worried about affording prescription drugs and support more regulation of prescription drug pricing (72%). Looking ahead to midterms, the Democratic party currently holds the advantage when it comes to who voters trust to address the cost of health care, including prescription drugs. Read the news release →
vaccines
Tracking Polling on Health Information and Trust
KFF’s new interactive polling dashboard draws on more than a dozen surveys to show trends in trust in health information, attitudes toward vaccines, and use of news, social media, and AI for health-related information.
new and noteworthy
What Medicare’s Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries
CMS’s efforts to expand Medicare coverage of GLP-1s for obesity could provide substantial benefits to millions of Medicare beneficiaries, given the potential demand for these highly effective medications…There are potential drawbacks to the short-term program, however.
How States Verify Citizenship and Immigration Status in Medicaid
This brief describes federal citizenship and immigration status eligibility and eligibility verification requirements for Medicaid. Eligibility for federally-funded coverage under Medicaid and the Children’s Health Insurance Program is limited to U.S. citizens and certain lawfully present immigrants.
Constrained Budgets Lead States to Restrict HIV Drug Access Through Ryan White
This policy watch explores how state Ryan White AIDS Drug Assistance Programs are responding to constrained budget pressures, including by restricting eligibility and reducing the scope of services offered, actions that could lead to negative health outcomes for people with HIV and lead to new HIV infections.
What Newly Released Medicaid Data Do and Don’t Tell Us
CMS released a dataset with provider-level spending data that the agency suggests could be used to identify unusual billing patterns for specific services, states, or providers. This policy watch describes the data and how they could potentially lead to mistaken conclusions given the data’s limitations.
Latest News
-
Doctors Warn of a Deadly Complication From Measles Outbreaks
-
Medicare Advantage ‘Dark Money’ Group Attempts To Win Higher Payments for Insurance Companies
-
Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms
-
As Lung Disease Threatens Workers, Lawmakers Seek Protections for Countertop Manufacturers
Subscribe to KFF Emails
Choose which emails are best for you.
Sign up here